IVAX Diagnostics Confirms That Its Policy is Not to Comment on Unusual Market Activity
14 Giugno 2011 - 7:44PM
Business Wire
IVAX Diagnostics, Inc. (NYSE Amex:IVD) today reported that, in
light of the unusual market activity in its stock, the NYSE Amex
contacted IVAX Diagnostics in accordance with the NYSE Amex’s usual
practice. IVAX Diagnostics confirmed that its policy is not to
comment on unusual market activity.
About IVAX Diagnostics, Inc.
IVAX Diagnostics, Inc. (www.ivaxdiagnostics.com), headquartered
in Miami, Florida, is a fully integrated in vitro diagnostics
company that develops, manufactures and distributes in the United
States and internationally, proprietary diagnostic reagents, test
kits and instrumentation, primarily for autoimmune and infectious
diseases, through its three subsidiaries: Diamedix Corporation
(U.S.), Delta Biologicals S.r.l. (Europe), and ImmunoVision, Inc.
(U.S.).
Grafico Azioni Ivax Diagnostics (AMEX:IVD)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Ivax Diagnostics (AMEX:IVD)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Ivax Diagnostics, Inc. (Borsa Americana (AMEX)): 0 articoli recenti
Più IVAX Diagnostics, Inc. Articoli Notizie